IFNG and tuberculosis: They may also have a positive interferon-gamma release assay (IGRA) or tuberculin skin test (TST) reaction of 5 or more millimetres at high risk of developing active disease and should receive anti-tuberculosis treatment to reduce such risk (Centers for Disease Control and Prevention 2022).